“zymeworks” Archives

in
Entry Author Date Location
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own 10/15/19 New York
Pandion Raises $58M to Bring Cancer-Fighting Tactics to Immune Disorders 01/18/18 Boston
Riding Recent Biotech IPO Wave, G1 Snags $105M to Fund Cancer Work 05/17/17 Raleigh Durham
With $75M Haul, Ovid Continues Flurry of Biotech IPOs 05/04/17 New York
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
Bio Roundup: Gottlieb Talks Vax, Acorda’s Axe, Adams, 23andMe & More 04/07/17 National
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
West Coast Bio Roundup: Big Waves, Big Cash & a Deep Pre-JPM16 Breath 01/08/16 San Francisco
West Coast Biotech Roundup: Zymeworks, Lee Hood, Sue Biggins, Nektar 01/22/15 Seattle
West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More 10/23/14 San Francisco
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Zymeworks Nabs $15M, Adds Lilly Partnership, in Antibody Drug Quest 01/09/14 Seattle
Zymeworks Hits Antibody Drug Milestone For Merck, Raises $11M 09/06/12 Seattle
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Page 1 of 1